INOVIO PHARMACEUTICALS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

INOVIO PHARMACEUTICALS, INC. reported Cash And Cash Equivalents At Carrying Value of $44.27 million for the year ending 2025.

  • INOVIO PHARMACEUTICALS, INC. showed a decrease of -32.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from INOVIO PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
  • XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 18 years of available data (2008 to 2025), INOVIO PHARMACEUTICALS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 213.7%.
  • Historical annual values: Fiscal year 2025: $44.27 million | Fiscal year 2024: $65.81 million | Fiscal year 2023: $14.31 million | Fiscal year 2022: $46.33 million | Fiscal year 2021: $71.14 million | Fiscal year 2020: $250.73 million | Fiscal year 2019: $22.20 million | Fiscal year 2018: $23.69 million | Fiscal year 2017: $23.79 million | Fiscal year 2016: $19.14 million | Fiscal year 2015: $57.63 million | Fiscal year 2014: $40.54 million | Fiscal year 2013: $33.72 million | Fiscal year 2012: $5.65 million | Fiscal year 2011: $17.35 million | Fiscal year 2010: $20.00 million | Fiscal year 2009: $30.30 million | Fiscal year 2008: $14.12 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: